scientific programmohamed farghaly industry sponsored rashid hall d symposium - novartis industry...

SCIENTIFIC PROGRAMSCIENTIFIC PROGRAM

www.edec-uae.com

27 - 29 February 2020, Dubai, UAE


02

*Pro

gram

sub

ject

to c

hang

e

Congress Secretariat: MCI Middle East, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail: [email protected]

Industry Sponsored Rashid Hall A Symposium - Pfizer

Industry Sponsored Rashid Hall DSymposium - Abbott

DAY 1 – THURSDAY, 27 FEBRUARY 2020

08:00 - 08:45 Registration & Welcome Coffee

08:45 - 09:00 Introduction & Opening Remarks Fatheya AlAwadi, Emirates Diabetes Society President Iyad Ksseiry, Scientific Committee Chairman

09:00 - 09:30 Endocrine - Diabetes UAE Data Rashid Hall E Chairpersons: Abdulrazzaq Ali Al Madani | Khaled Al Dahmani

09:00 – 09:15 Vitamin B12 Replacement Post Bariatric Surgery Juma Alkaabi, UAE

09:15 – 09:30 Dubai Diabetes Registry – KPI’s Fatheya Alawadi, UAE

09:30 - 10:30 UAE Diabetes Society - Type 2 Diabetes Guidelines Rashid Hall E Chairpersons: Abdulrazzaq Ali Al Madani | Khaled Al Dahmani

09:30 – 09:35 Why do we need National Diabetes Guidelines? Fatheya Alawadi, UAE

09:35 – 09:50 Screening and Monitoring for Type 2 Diabetes Huda Ezzedine, UAE

09:50 – 10:05 Pharmacotherapy Overview Mohamed Hassanein, UAE

10:05 – 10:30 Q&A All Speakers

10:30 – 11:00 Opening Ceremony Rashid Hall E

11:00 – 11:30 Opening Exhibition, Coffee Break

11:30 – 13:00 Session 1: State of Art Lectures Rashid Hall E Chairpersons: Elham Al Amiri | Juma Al Kaabi

11:30 – 12:00 Primary Hyperparathyroidism: 7,000 Years of Progress Michael Levine, USA

12:00 – 12:30 Real World Evidence: The Utility in Evaluating Diabetes Treatments John Buse, USA

12:30 – 13:00 Diabetic Foot in 2020 Andrew Boulton, UK

13:00 – 14:15 Lunch Break / Poster Session / Product Theater

13:05 - 13:35 Industry Sponsored Symposium - Boehringer Ingelheim Rashid Hall D

13:40 – 14:10 Industry Sponsored Symposium - Sanofi Rashid Hall D

14:15 - 16:15

14:15 – 14:55

14:55 – 15:35

15:35 – 16:15

Session 2 - Rashid Hall D Endocrine Updates Chairpersons: Hussein Saadi | Jalal Nafach

What’s New in the Diagnosis and Treatment of HypopituitarismMargaret Wierman, USA

Thyroid Nodules, Evaluation and Management Douglass Ross, USA

New Insights into Assessment and Management of Polycystic Ovary SyndromeRicardo Azziz, USA

Early Identification of Peripheral Arterial Disease in DiabetesAndrew Boulton, UK

Growth Hormone Deficiency in ChildrenMichael Levine, USA

An Updated Review of Lipid-modifying TherapyStephane Heymans, Belgium

Metabolic Bone Diseases Case Scenarios Michael Levine, USA

Review of Recent Cardiovascular Outcome TrialsJohn Buse, USA

Prevention and Cure of Type 1Diabetes: Where are we StandingNow?Thomas Danne, Germany

Session 3 - Rashid Hall E Managing CV Risk in DiabetesChairpersons: Ahmed Hassoun | Abdullah Ben Nakhi

Session 4 - Rashid Hall A Pediatric EndocrinologyChairpersons: Asma Jassim | Elham Al Amiri

16:15 - 17:00


03

*Pro

gram

sub

ject

to c

hang

e


DAY 2 – Friday, 28 FEBRUARY 2020


08:30 - 09:30 Session 5 - Diabetes Complications Rashid Hall E Chairpersons: Muhammad Farooqi | Mohamed Railey

08:30 - 09:00 Clinical Management of Diabetic Neuropathy Andrew Boulton, UK

09:00 – 09:30 Updates on Slowing Progression of Diabetic Kidney disease – George Bakris, USA Focus on Novel Therapies

09:30 – 10:00 Coffee Break / Product Theater

10:00 – 11:00 Session 6 - Androgens Rashid Hall E Chairpersons: Abdulrazzaq Ali Al Madani | Hussein Saadi

10:00 - 10:30 Does Everyone Have Low Testosterone? Margaret Wierman, USA 10:30 – 11:00 The Phenotype of Hirsute Women: Investigations and Management Ricardo Azziz, USA

11:00 - 12:00 Session 7 - State of Art Lectures Rashid Hall E Chairpersons: Mohammed Hassanein | Asma Jasim

11:00 - 11:30 Recent Advances in Treatment of Diabetes? John Buse, USA

11:30 – 12:00 Emerging Technologies in Diabetes Thomas Danne, Germany

12:00 - 14:15 Friday Prayer / Poster Session / Lunch Break / Product Theater

13:00 – 13:30 Industry Sponsored Symposium - Novo Nordisk Rashid Hall D

13:35- 14:05 Industry Sponsored Symposium - Lilly Rashid Hall D

14:15 – 16:15

14:15- 14:45

14:45 - 15:15

15:15 -15:45

15:45 -16:15

Session 8 - Rashid Hall D Women’s HealthChairpersons: Sara Suliman | Huda Ezzedine

The Objectives of Hyperprolac-tinemia TherapyJohn Wass, UK

Menopausal Hormone Therapy and AlternativesMargaret Wierman, USA

Infertility Treatment Related to Polycystic Ovary SyndromeRicardo Azziz, USA

Strategies in the Management ofType 1 versus Type 2 Diabetes inPregnancyNeda Rasouli, USA

Will Technology Change the Future of Diabetes?Osama Hamdy, USA

Should Metformin Remain the First Line of Therapy for Type 2 DiabetesNeda Rasouli, USA

Understanding the Link BetweenCardiovascular Disease and Diabetic Kidney DiseaseGeorge Bakris, USA

Adjunctive Therapy in Type 1 Diabetes: Anything Useful Beyond Insulin?John Buse, USA

Nutrition Reinvented in the Management of DiabetesOsama Hamdy, USA

Unusual Presentations of ThyroidDiseaseDouglas Ross, USA

Session 9 - Rashid Hall EHot Topics in DiabetesChairpersons: Glenn Matfin | Ahmed Hassoun

Session 10 - Rashid Hall A Meet the ExpertChairpersons: Aly Khalil | Mohamed Farghaly

Industry Sponsored Rashid Hall DSymposium - Novartis

Industry Sponsored Rashid Hall ASymposium - MSD 16:15 - 17:00

Diabetes Education / Nutrition Workshop - Rashid Hall DChairperson: Sara Adhami

10:00 - 11:00 Structured Diabetes

Education

Trudi Deakin, UK


04

*Pro

gram

sub

ject

to c

hang

e


DAY 3 – SATURDAY, 29 FEBRUARY 2020


08:30 - 09:30 Session 11 – Thyroid Rashid Hall E Chairpersons: Abdulrazzaq Ali Al Madani | Alaaeldin Bashier

08:30 - 09:00 Update on Thyroid Disease in Pregnancy Neda Rasouli, USA

09:00 – 09:30 Low Risk Thyroid Cancer: Evidence, Expert Opinion and Common Sense Douglas Ross, USA

09:30 – 10:30 Oral Presentations

10:30 – 11:00 Coffee Break / Product Theater

11:00 – 13:00

11:00 – 11:30

11:30 – 12:00

12:00 – 12:30

12:30 – 13:00

Session 12 - Rashid Hall D Challenges and ControversiesChairpersons: Salah Abusnana | Khaled Al Dhamani

Congenital Adrenal Hyperplasia:A Patient-Centered ApproachMargaret Wierman, USA

Subclinical Thyroid Disease Douglas Ross, USA

Gestational Diabetes Mellitus: Glycemic Control and Maternal Prognosis.Neda Rasouli, USA

Acromegaly in 2019: More Clarity, Less ControversiesJohn Wass, UK

The Position of Nutrition andDiabetes Education in the GuidelinesTrudi Deakin, UK

Perspective on the New Blood Pressure GuidelinesGeorge Bakris, USA

Deciding on an SGLT2i or GLP1ra from Cardiology Perspective in ESC GuidelinesStephane Heymans, Belgium

Guide to Efficient Obesity Management in DiabetesOsama Hamdy, USA

Case Based Discussion of Difficult Pituitary CasesJohn Wass, UK

Resistant Hypertension: A Case Based PresentationGeorge Bakris, USA

Session 13 - Rashid Hall EGuidelinesChairpersons: Ossama Barakat | Muhammad Farooqi

Session 14 - Rashid Hall AMeet the ExpertChairpersons: Elamin Abdelgadir | Khadija Hafidh

13:00 - 14:00 Session 15: State of Art Lectures Rashid Hall E Chairpersons: Monira Alarouj | Mohammed Hassanein

13:00 - 13:30 Should Cardiologist be Familiar with Anti-Diabetes Medications? John Buse, USA

13:30 - 14:00 Should Endocrinologists Screen for Asymptomatic Cardiovascular Stephane Heymans, Disease and Heart Failure? Belgium

14:00 Closing Remarks

Diabetes Education / Nutrition Workshop - Rashid Hall DChairperson: Zeina Younes

8:30 - 9:30 Counting Carbohydrate /

Insulin Pump

Trudi Deakin, UK

INDUSTRY SYMPOSIUMS

13:05 - 13:35 - Rashid Hall DConsensus Recommendation for Management of Type 2 Diabetes Patients with Cardiovascular Disease

Speaker: Al Amin Ibrahim, UAE

13:40 – 14:10 - Rashid Hall D

Individualizing Diabetes Care – The Role of GLP1ra and Insulin Combination. What to Expect? Who Can Benefit?Speaker: Alaaeldin Bashir, UAE

16:15 - 16:35 - Rashid Hall A

Chairperson: Ahmed Hassoun, MD (UAE)

Global & Regional Recommendations for Adult Pneumococcal Vaccination – a View From a Public Health Prospective

Speaker: Faryal Khamis, MD (Oman)

16:35 - 16:55

The Risk of LRTIs in Adult Age Group with Diabetes – What do we know so far?

Speaker: Khadija Hafidh, MD (UAE)

16:55 - 17:00

Q&A - Closing remarks

16:15 - 17:00 - Rashid Hall D

Sensor-Based Data to Optimise Diabetes Care: Standardized Metrics and Real-World Data

Speaker: Mohammed Al-Khatib, UAE


Sponsored by

Sponsored by

Sponsored by

Sponsored by


05Congress Secretariat: MCI Middle East, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail: [email protected]

PRODUCT THEATER

11:10 - 11:25 Obesity Management: Are we on Right Track?Speaker: Rita Nawar

13:05 – 13:35 Trulicity Efficacy in RCTs and RWE Studies for Type 2 DiabetesSpeaker: Shenaz Sedat

13:40 – 14:10 The DUAL power to intensify diabetes treatmentSpeaker: John Buse


Sponsored by

Sponsored by

Sponsored by

INDUSTRY SYMPOSIUMS


06Congress Secretariat: MCI Middle East, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail: [email protected]

13:00 – 13:30 - Rashid Hall D

Expanding treatment options for Type 2 diabetes with Semaglutide: What to Expect from the New Kid on the BlockChairperson: Juma M. Al KaabiSpeaker: John Buse

13:35- 14:05 - Rashid Hall DTBC

Speaker: TBC

16:15 - 17:00 - Rashid Hall ATargeting the Core Defects Underlying Type 2 DiabetesSpeaker: Dr.Tarek Fiad, UAE

16:15 - 17:00 - Rashid Hall DVERIFYing the early treatment intensification in T2DMSpeaker: Dr. Mohamed Hassanein | Dr. Salah Abusnana, UAE

DAY 2 – FRIDAY, 28 FEBRUARY 2020

Sponsored by

Sponsored by

Sponsored by

Sponsored by

PRODUCT THEATER

13:00 - 13:30

Unpresedented Resistance and Revolutionary Combination for T2DM (Alogliptin, Pioglitzone)

Speaker: Jalal Nafach, UAE

09:35 - 09:50

Introducing One Touch Verio Reflect™ Meter “Moving From Monitoring to Mentoring”

Speaker: Amr Hamada

13:35 - 14:05

How Does Effective Titration Provide a Lasting Impact for T2DM Patients on Basal Insulin? A Case-Based Approach

Speaker: Bahaa Grace, UAE

DAY 2 – FRIDAY, 28 FEBRUARY 2020

Sponsored by

Sponsored by

Sponsored by

scientific programmohamed farghaly industry sponsored rashid hall d symposium - novartis industry...

Documents